Press release
Leading Element Driving Change in the mRNA Therapeutics Market in 2025: Impact Of Long-Lasting And Communicable Diseases On mRNA Therapeutics Market Driver
mRNA Therapeutics Market Size
The market size of mRNA therapeutics has witnessed a steady uptick in recent years. The market's value is set to amplify from $34.76 billion in 2024 to $36.25 billion in 2025, at a compound annual growth rate (CAGR) of 4.3%. The escalation during the historic period can be traced back to factors such as increased financial backing for the development of effective drugs and vaccines, the enlargement of government initiatives dedicated to promoting RNA-based treatments, heightened awareness of rare genetic diseases, and the escalating number of clinical trials.
Steady growth is anticipated for the size of the mRNA therapeutics market in the forthcoming years, with projections estimating a rise to $42.23 billion in 2029, boasting a compound annual growth rate (CAGR) of 3.9%. This growth in the forecast period is said to be influenced by a rise in infectious diseases, a surge in patients seeking care in hospitals and clinics, enlarging the scope of mRNA therapeutics, a rise in demand for precision and personalized medicine, supportive regulatory environments, and expedited approval processes. Upcoming trends within the same forecast period encompass advancements in technologies used for mRNA delivery, swift progression and adaptation of mRNA vaccines, the advent of self-amplifying mRNA (saRNA) platforms, scalable and adaptable mRNA manufacturing, and the creation of unique mRNA modifications.
What Are the Main Catalysts for Growth in the mRNA Therapeutics Market?
The rise in long-term and infectious diseases is projected to spur the growth of the mRNA therapeutics market. Long-term and infectious diseases, like tuberculosis, HIV/AIDS, and hepatitis, which continue for a longer period and can be transferred from person to person, have become more prevalent. Factors such as increased worldwide travel and insufficient healthcare structure contribute to the rising prevalence, by making it easier for these diseases to spread and harder to manage them effectively. mRNA therapeutics can play a crucial role in combating these infectious and long-lasting diseases as it accelerates the body's production of proteins that amplify immune responses, which leads to the faster creation of vaccines and treatments. For example, in October 2023, GOV.UK revealed that in 2022, the number of people in England who were diagnosed with HIV and under treatment was 94,397, up by 3% from 91,368 in 2021. Thus, the rising prevalence of long-term and infectious diseases is a key driving force for the expansion of the mRNA therapeutics market.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=17205&type=smp
Who Are the Dominant Companies Influencing mRNA Therapeutics Market Trends?
Major companies operating in the mRNA therapeutics market are Pfizer Inc., Novartis AG, Sanofi AG, AstraZeneca plc, GlaxoSmithKline plc, Hoffmann-La Roche AG, Moderna Therapeutics Inc, BioNTech SE, Vertex Pharmaceuticals Incorporated, Catalent Inc, Alnylam Pharmaceuticals Inc, Sarepta Therapeutics Inc, Arcturus Therapeutics Holdings Inc, CureVac N.V, Ethris GMBH, eTheRNA immunotherapies NV, In-Cell-Art S.A.S., Nutcracker Therapeutics Inc, SCM LifeScience Co Ltd, Suzhou Abogen Biosciences Co Ltd, Tiba Biotech LLC, CSPC Pharmaceutical Group, CRISPR Therapeutics AG
How Is the mRNA Therapeutics Market Evolving?
Leading businesses in the mRNA therapeutics market are honing their focus on creating ground-breaking solutions such as mRNA-based booster vaccines, designed to strengthen immunity against increasingly mutating viral variants. Essentially, an mRNA-based booster vaccine employs messenger RNA (mRNA) technology to bolster and extend immunization against particular pathogens, particularly following the primary vaccination sequence. In June 2023, for example, Gennova Biopharmaceuticals Ltd., a pharmaceutical firm based in India, introduced GEMCOVAC-OM, India's pioneer mRNA-based Omicron-specific booster vaccine. This variant-targeted vaccine aims to evoke the necessary immune responses against the Omicron variant of SARS-CoV-2. Remarkably, GEMCOVAC-OM is thermally stable, does not require ultracold chain infrastructure, and can be delivered without a needle using a needle-free device system, making it highly suitable for final-mile distribution in India. Clinical trials of the vaccine have indicated marked improved immune responses relative to other vaccines, highlighting the necessity of variant-targeted vaccines to trigger the needed immune responses.
What Are the Different Segmentations in the mRNA Therapeutics Market?
The mRNA therapeutics market covered in this report is segmented -
1) By Product: Vaccines, Drugs
2) By Application: Infectious Diseases, Oncology, Rare Genetic Diseases, Respiratory Diseases, Other Applications
3) By End Use: Hospitals And Clinics, Research Organizations, Other End Uses
Subsegments:
1) By Vaccines: Infectious Disease Vaccines, Cancer Vaccines, Other Therapeutic Vaccines
2) By Drugs: Oncology Drugs, Cardiovascular Drugs, Autoimmune Disease Drugs, Other mRNA-Based Drugs
Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/mrna-therapeutics-global-market-report
Which Region Is at the Forefront of the mRNA Therapeutics Market?
North America was the largest region in the mRNA therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mRNA therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Is Covered In The mRNA Therapeutics Global Market Report?
- Market Size Analysis: Analyze the mRNA Therapeutics Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the mRNA Therapeutics Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall mRNA Therapeutics Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the mRNA Therapeutics Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=17205
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Leading Element Driving Change in the mRNA Therapeutics Market in 2025: Impact Of Long-Lasting And Communicable Diseases On mRNA Therapeutics Market Driver here
News-ID: 3863701 • Views: …
More Releases from The Business Research Company
Polymeric Biomaterials Industry Growth Outlook: 15.9% CAGR and $125.13 Billion b …
Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments.
What Is the Long-Term Growth Forecast for the Polymeric Biomaterials Market Size 2025?
The market size for polymeric biomaterials has experienced significant growth lately. Its size is projected to increase from $59.69 billion in 2024 to $69.32 billion in 2025, signaling a compound annual growth rate (CAGR) of 16.1%. Factors influencing the…
Global Organometallics Market Expansion at 5.8% CAGR, Valued at $3.93 Billion by …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
What Are the Organometallics Market Size Forecast for 2025?
In recent years, the organometallics market has seen a robust growth. The market value is projected to rise from $2.98 billion in 2024 to $3.14 billion in 2025, marking a compound annual growth rate (CAGR) of 5.4%. Several factors have propelled…
Medical Isotopes Market on Path to Hit $9.5 Billion by 2029 at 7% CAGR
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
Medical Isotopes Market Outlook: What Size And CAGR Are Anticipated By 2025?
The market size for medical isotopes has seen robust growth in the past few years. It's projected to expand from $6.8 billion in 2024 to $7.26 billion in 2025, with a compound annual growth rate (CAGR) of 6.7%.…
Future of Homogeneous Precious Metal Catalyst Market: Size, Share & Forecasts to …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
What Is the Projected Market Size Valuation of the Homogeneous Precious Metal Catalyst Market by 2025?
The market size of the uniform precious metal catalyst has seen a swift expansion in the recent past. Its growth is projected to leap from $2.65 billion in 2024 to $2.94 billion in 2025, exhibiting…
More Releases for RNA
CD Formulation Launches Custom Circular RNA Synthesis Service to Accelerate RNA …
CD Formulation introduces a customizable circRNA synthesis service, delivering high-quality, stable circRNAs for therapeutics, vaccines, and gene research, supported by advanced design and QC processes.
CD Formulation, a leading provider of advanced small nucleic acid synthesis [https://www.formulationbio.com/nucleic-acid/custom-small-nucleic-acid-synthesis.html] solutions, is proud to announce the launch of its fully customizable circular RNA (circRNA) synthesis service. This new service addresses the growing need for stable, non-immunogenic RNA molecules for therapeutic development, vaccine research, and…
Self-Amplifying RNA Synthesis Market Gains Traction as Biotech Firms Embrace Sca …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Self-Amplifying RNA Synthesis Market- (By Product & Service (Products (Enzymes & Reagents, Premade saRNA, Others), Custom Synthesis Services), By Application (Therapeutics Development (Oncology, Infectious Diseases, Others), Biomedical Research), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic,…
RNA Extraction and RNA Purification Market: Growth, Trends & Competitive Landsca …
The global RNA Extraction and RNA Purification Market is expected to grow at 6.3% CAGR from 2025 to 2032.
This Market Report is the result of extensive research and analysis conducted by our team of experienced market researchers through -
• 70% efforts of Primary Research
• 15% efforts of Secondary Research
• 15% efforts from the subscription to Paid database providing industry overview, macro and micro economics factors, and financials of private limited…
RNA Targeting Small Molecules Therapeutics Market: Exponential Growth with Risin …
Estimations Predict a CAGR of 29.8% by 2029 in Global RNA Targeting Small Molecules Therapeutics Market Boosted by Precision Medicine, RNA Biomarker Identification and RNA Genetic Manipulation
What Is The Projected Market Size of The Global RNA Targeting Small Molecules Therapeutics Market And Its Growth Rate?
• The market will grow from $6.1 billion in 2024 to $7.87 billion in 2025 at a compound annual growth rate (CAGR) of 28.9%.
• Expected exponential…
Global DNARNA Extraction Kit Market by Type (Cell-free DNA (cfDNA), Sequence-spe …
"DNARNA Extraction Kit Market" is segmented by Company, Region (country), By Type, Application, stakeholders and other participants. This report provides an analysis of revenue and forecast across Type and Application segments for 2023-2032.
The market for DNARNA Extraction Kits has been thoroughly researched via primary and secondary sources to produce this research study. Along with a competitive analysis of the market, segmented by application, type, and geographical trends, it offers a…
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may…
